Breast cancer hormonal therapy
OwnerGiorgio Massimini, Robert Paridaens +2inventors
InventorsGiorgio Massimini, Robert Paridaens, Jean-Pierre Lobelle, Gabriella Piscitelli
Life of this patent
Estimating the term…
Abstract
Exemestane is disclosed for use in the first-line treatment of metastatic, advanced hormone-dependent breast cancer, particularly in post-menopausal woman.
Claims17
Use of exemestane in the preparation of a pharmaceutical composition for use in first-line treatment of metastatic, advanced hormone-dependent breast cancer.
A method for the first-line treatment of metastatic, advanced hormone-dependent breast cancer comprising administering to a patient, in need of such first-line treatment, a therapeutically effective amount of exemestane or a pharmaceutical composition containing it.
A method for the first-line treatment of metastatic, advanced hormone-dependent breast cancer comprising orally administering to a patient, in need of such first-line treatment, a therapeutically effective amount of exemestane ranging from about 5 to about 50 mg/day or a pharmaceutical composition containing it.
A method for the first-line treatment of metastatic, advanced hormone-dependent breast cancer comprising administering to a postmenopausal woman, in need of such first-line treatment, a therapeutically effective amount of exemestane or a pharmaceutical composition containing it.
A method for the first-line treatment of metastatic, advanced hormone-dependent breast cancer comprising orally administering to a postmenopausal woman, in need of such first-line treatment, a therapeutically effective amount of exemestane ranging from about 5 to about 50 mg/day or a pharmaceutical composition containing it.
A method for the first-line treatment of metastatic, advanced hormone-dependent breast cancer comprising parenterally administering to a postmenopausal woman, in need of such first-line treatment, a therapeutically effective amount of exemestane ranging from about 50 to about 500 mg or a pharmaceutical composition containing it.
Dependencies are inferred from the claim text.